K Michael Gibson - JoVE Visualize

Showing results (81-90 of 148) with videos related to

Pageof 15

Sort By:

Annals of Neurology|October 22, 2005

Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanismsYing Wu, Andrea Buzzi, Marina Frantseva, et al.

Molecular Genetics and Metabolism|September 5, 2002

Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoformsPaola Blasi, Pietro Pilo Boyl, Mario Ledda, et al.

Biophysical Journal|February 1, 2023

Allosteric modulation of α1β3γ2 GABA<sub>A</sub> receptors by farnesol through the neurosteroid sitesJeevan B Gc, Christopher T Szlenk, Ayobami Diyaolu, et al.

Biological Psychiatry|September 27, 2003

Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria)K Michael Gibson, Maneesh Gupta, Phillip L Pearl, et al.

Journal of Child Neurology|February 9, 2021

Postmortem Analyses in a Patient With Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): II. Histological, Lipid, and Gene Expression Outcomes in Regional Brain TissueDana C Walters, Regan Lawrence, Trevor Kirby, et al.

Journal of Inherited Metabolic Disease|February 21, 2018

Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategiesKara R Vogel, Garrett R Ainslie, Dana C Walters, et al.

Neurology|February 14, 2014

Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABAPhillip L Pearl, John Schreiber, William H Theodore, et al.

Epilepsy Research|January 1, 2021

Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicityDana C Walters, Erwin E W Jansen, Gajja S Salomons, et al.

Pediatrics|February 4, 2003

Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrumViola Prietsch, Ertan Mayatepek, Hermann Krastel, et al.

Bioorganic & Medicinal Chemistry|April 1, 2017

Indole-TEMPO conjugates alleviate ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial functionWei Bi, Yue Bi, Xiang Gao, et al.

Pageof 15

Showing results (81-90 of 148) with videos related to

Sort By:

Pageof 15

Annals of Neurology|October 22, 2005

Status epilepticus in mice deficient for succinate semialdehyde dehydrogenase: GABAA receptor-mediated mechanismsYing Wu, Andrea Buzzi, Marina Frantseva, et al.

Molecular Genetics and Metabolism|September 5, 2002

Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoformsPaola Blasi, Pietro Pilo Boyl, Mario Ledda, et al.

Biophysical Journal|February 1, 2023

Allosteric modulation of α1β3γ2 GABA<sub>A</sub> receptors by farnesol through the neurosteroid sitesJeevan B Gc, Christopher T Szlenk, Ayobami Diyaolu, et al.

Biological Psychiatry|September 27, 2003

Significant behavioral disturbances in succinic semialdehyde dehydrogenase (SSADH) deficiency (gamma-hydroxybutyric aciduria)K Michael Gibson, Maneesh Gupta, Phillip L Pearl, et al.

Journal of Child Neurology|February 9, 2021

Postmortem Analyses in a Patient With Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): II. Histological, Lipid, and Gene Expression Outcomes in Regional Brain TissueDana C Walters, Regan Lawrence, Trevor Kirby, et al.

Journal of Inherited Metabolic Disease|February 21, 2018

Succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism: an update on pharmacological and enzyme-replacement therapeutic strategiesKara R Vogel, Garrett R Ainslie, Dana C Walters, et al.

Neurology|February 14, 2014

Taurine trial in succinic semialdehyde dehydrogenase deficiency and elevated CNS GABAPhillip L Pearl, John Schreiber, William H Theodore, et al.

Epilepsy Research|January 1, 2021

Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicityDana C Walters, Erwin E W Jansen, Gajja S Salomons, et al.

Pediatrics|February 4, 2003

Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrumViola Prietsch, Ertan Mayatepek, Hermann Krastel, et al.

Bioorganic & Medicinal Chemistry|April 1, 2017

Indole-TEMPO conjugates alleviate ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial functionWei Bi, Yue Bi, Xiang Gao, et al.

Pageof 15